- Stocks
- Cement & Materials
- EP Biocompo
EP Biocompo share price
NSE: EPBIOCement & MaterialsBuilding Products & Equipment
EP Biocompo at a glance
With a market capitalisation of ₹17 Cr, it ranks 3660th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Cement & Materials sector; its industry is Building Products & Equipment.
Its return on equity was 12.1% in FY26. Promoters held 70.08% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹17 CrRank 3660 on NSE
- Price to book
- 1.17×FY26
- ROE
- 12.1%FY26
- ROCE
- 16.2%FY26
- Debt to equity
- 0.2FY26
- Net profit margin
- 10.7%FY26
- Book value / share
- ₹71.68FY26
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
EP Biocompo financials
| Item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹7 Cr | ₹11 Cr | ₹12 Cr | ₹14 Cr |
| Operating profit | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
| Net profit | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| EPS (₹) | ₹3.94 | ₹6.84 | ₹6.13 | ₹8.67 |
| Cash from operations | −₹1 Cr | −₹1 Cr | −₹0 Cr | ₹2 Cr |
| Total debt | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr |
| Shareholders' equity | ₹8 Cr | ₹10 Cr | ₹11 Cr | ₹12 Cr |
EP Biocompo shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 70.08% | 70.08% | 70.05% | 70.08% | 70.08% | 70.08% |
| Non-institutions | 29.92% | 29.92% | 29.95% | 29.92% | 29.92% | 29.92% |
EP Biocompo vs peers
The listed Cement & Materials companies nearest to EP Biocompo by market capitalisation.
Ask anything about EP Biocompo
Pivot answers on the live chart with evidence you can check, and tests strategies against EPBIO's own history. Try: “Why has EPBIO moved over the last three months?” · “Backtest a 50-day moving-average crossover on EPBIO over five years” · “Compare EPBIO with NEELKAN on margins and valuation”
Frequently asked questions about EP Biocompo
What is the market cap of EP Biocompo?
EP Biocompo's market capitalisation is ₹17 Cr (₹17 Cr) at the 22 Oct 2026 close, ranking 3660th among the NSE companies Pivot tracks.
What is the ROE and ROCE of EP Biocompo?
Return on equity was 12.1% in FY26 and return on capital employed was 16.2% in FY26 (standalone figures).
Is EP Biocompo a debt-free company?
No. EP Biocompo's debt-to-equity ratio was 0.2 in FY26, with total debt of ₹2 Cr.
What is the shareholding pattern of EP Biocompo?
As of 30 Jun 2026: promoters 70.08%, non-institutions 29.92%.
Who are EP Biocompo's competitors?
The listed Cement & Materials companies closest to EP Biocompo by market cap are Neelkanth Rock, Rajeshwari, Manas Polymers, Vamshi Rubber, Kunststoffe Ind and ADHATA GLOBAL.
Is EP Biocompo a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out EP Biocompo's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on EPBIO against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Cement & Materials stocks · companies starting with E · all NSE stocks · this page as text